drugset / Trial / NCT00765206

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

NCT00765206

Phase 3 Completed 60 enrolled Bayer Bausch Health Americas, Inc. · collab
RandomizedCrossoverOpen-label

Summary

Open-label randomized crossover design study. 60 participants will be evaluated on Day 1 to compare effects on stomach acid; 30 participants will continue treatment for 7 days and will have repeat evaluations at Day 7.

Timeline

Start
2008-05
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 20 mg
Subject sodium bicarbonate Diagnostic / imaging agent 1100 mg

Indications

No indication recorded.